Trials / Completed
CompletedNCT01148745
Iron Indices and Intravenous Ferumoxytol: Time to Steady State
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Dialysis Clinic, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the time point of transferrin saturation (TSAT) and ferritin stabilization after a thirteen-treatment period following a ferumoxytol load, as well as to determine the point at which serum ferritin and TSAT concentrations can be checked in iron deficiency anemia (IDA) hemodialysis patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ferumoxytol | 510 milligram (mg) intravenous (IV) injection (30 mg/second (sec) over 17 seconds) after at least one hour of hemodialysis (HD), second 510 mg IV injection administered at next consecutive dialysis treatment (3-5 days after first injection) |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-04-01
- Completion
- 2010-05-01
- First posted
- 2010-06-22
- Last updated
- 2012-03-30
- Results posted
- 2012-03-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01148745. Inclusion in this directory is not an endorsement.